Primary PCI Monitoring Performance

Slides:



Advertisements
Similar presentations
Local improvement following national clinical audit workshops Auditing heart attacks Saving lives Dr Andrew Wragg Barts Health.
Advertisements

NO CONFLICT OF INTEREST TO DECLARE J.M. McLENACHAN, LEEDS.
Radial versus Femoral Randomized Investigation in ST Elevation Acute Coronary Syndrome the RIFLE STEACS study Enrico Romagnoli, MD PhD Principal investigators:
PPCI – National Update NCBC Workshop Jim McLenachan, National Clinical Lead for PPCI, NHS Improvement, England. London, 24 th November, NCBC Annual.
University Medical Center Groningen Thrombus aspiration during primary PCI FZ Thrombus Aspiration during Percutaneous coronary intervention in Acute.
Professor Roger Boyle CBE National Director for Heart Disease and Stroke Department of Health PCI in the UK: Fit for service? A view from the Department.
Interventional Registries The Audit and Research Potential of the BCIS CCAD Registry Peter F Ludman.
Around-the-Clock Primary Angioplasty: A Process of Care Analysis Comparing Off-Hours and Normal Hours Treatment of Acute STEMI R Leung, D Lundberg, D Galbraith,
Authors: Somkereki Cristina, Dr. Hadadi L.
Forsyth ML Receiving Center Report New Slide for Transfer in patients #2.
CPORT- E Trial Randomized trial comparing outcomes of non-primary PCI at hospitals with and without on-site cardiac surgery.
1 Primary Angioplasty for Acute STEMI Dr Adam Jacques Dr Sola Odemuyiwa February 2010.
Myocardial Ischaemia National Audit Project Are we replacing good fibrinolytic treatment with poor primary PCI? John Birkhead who has NO CONFLICT OF INTEREST.
AICT 2010-Athens Interventional Cardiovascular Therapeutics XI 8-9 OCTOBER 2010 Divani Caravel Hotel, Αthens EARLY CLINICAL OUTCOMES AFTER PROMUS ELEMENT.
Version: 1.1 Dated: 04/10/ ,000 Days Campaign Dashboard September 2012 Campaign Manager : Diana Dowdle Clinical Leader: David Grayson Improvement.
Retrograde approach for the Recanalizaiton of Coronary CTO: Preliminary Experience of Single Centre Lei Ge, Juying Qian, Xuebo Liu, Qin Qing, Junbo Ge.
AA 2008 Session III: STEMI The UK data Mark de Belder The James Cook University Hospital Middlesbrough.
Lysis and Beyond: ESC Guidelines and Reality J N Townend Queen Elizabeth Hospital Birmingham.
Endeavor Safety: Pooled Analysis of Early and Late Safety of a Zotarolimus-Eluting Stent Laura Mauri, MD, MSc Brigham and Women’s Hospital Harvard Clinical.
Acute Coronary Syndromes SIGN 93. MINAP Mortality after Acute Coronary Syndromes Cumulative: 13.6% Blue 10.6% Green 11.6% Red.
West Hertfordshire Primary Angioplasty Service Masood Khan.
Presenter Disclosure Information Kevin Daniel, RN, CEN Clinical Data Supervisor Northside Hospital System Metro Atlanta Mission Lifeline Quality & Data.
PCI v CABG Dr Rod Stables The Cardiothoracic Centre Liverpool UK.
Door to Balloon Time: Does it Matter? Tale of Two Studies.
© 2008 Delmar Cengage Learning. Chapter 6 Length of Stay/Discharge Days.
Dr Martyn Thomas Kings College Hospital Primary angioplasty “A UK Experience” “The UK experience”
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki.
High-risk ST elevation MI patients (>4 mm elevation), Sx < 12 hrs 5 PCI centers (n=443) and 22 referring hospitals (n=1,129), transfer in < 3 hrs High-risk.
Cardioprotective Effects of Postconditioning in Patients Treated with Primary PCI Evaluated with Magnetic Resonance Jacob T Lønborg Niels Vejlstrup, Erik.
St Asaph - November 2015 Dr Richard Anderson Consultant Cardiologist Senior Lecturer University Hospital of Wales, Cardiff, UK Wales Audit Data
MINAP: MINAP: Equity of Access in the National Databases in Wales? Swansea University/ABMU, NICOR Swansea University/ABMU,
End points in PTCA trials. A successful angioplasty is defined as the reduction of a minimum stenosis diameter to
Matching methods for estimating causal effects Danilo Fusco Rome, October 15, 2012.
M-Guard stent in STEMI patients with high thrombus burden lesions Mahmoud Shabestari Baktash Bayani Ali Eshraghi Bahram Shahri Mashhad University.
l asthma nnovation in quality improvement of care in children
Post-FDA Approval, Initial US Clinical Experience with Watchman Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation Vivek Y. Reddy.
The OPTIMAX first-in-man study Mid-term clinical outcome of Titanium-Nitride-Oxide-coated Cobalt Chromium stents in patients with de novo coronary artery.
Disrupt CAD Study Design
Post-FDA Approval, Initial US Clinical Experience with Watchman Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation Vivek Y. Reddy.
Myocardial Injury after Noncardiac Surgery and Association with Short Term Mortality Wilton A van Klei Anesthesiologist and acting chair Department Anesthesiology,
Urban and rural implementation of prehospital STEMI diagnosis
Published Reports The Trauma Audit & Research Network (TARN)
SEPSIS COLLABORATIVE Clinical Measures Scorecard Classification
What Have We Learned From the Mission: Lifeline Registry?
Quality Indicators Oct, Nov, Dec
Hospital statistics.
Cost Effective Use of Troponin to Rule Out Acute Coronary Syndrome
Heart Disease in the Acute Hospital
On-Site Surgical Back-up is ‘Critically’ Important for PCI!
Singapore’s Experience in Primary PCI in the Last Ten Years
Volume 384, Issue 9957, Pages (November 2014)
Date: Presenter: Ryan Chen
Invasive versus conservative treatment in unstable coronary syndromes
Figure 1 PCI strategies in patients with STEMI and multivessel disease
Primary PCI Monitoring Performance
The European Society of Cardiology Presented by RJ De Winter
Volume 384, Issue 9957, Pages (November 2014)
Dr S Rochow. Clinical Lead, Triage Unit. Woodend Hospital
Mid and South West Wales Primary Angioplasty update
Ischemic Postconditioning
China PEACE risk estimation tool for in-hospital death from acute myocardial infarction: an early risk classification tree for decisions about fibrinolytic.
Martin B. Leon, David R. Holmes, Dean J. Kereiakes, Jeffrey J
DEScover: One-Year Clinical Results
European Heart Journal Advance Access
DANAMI 3-DEFER Trial design: Patients presenting with STEMI and in whom the operators could establish TIMI 2-3 flow without stenting or those presenting.
Atlantic Cardiovascular Patient Outcomes Research Team
INTRO AMI. INTEGRILIN AND. REDUCED DOSE. OF THROMBOLYTIC IN. ACUTE
Consultant Clinical Biochemist
TYPHOON Trial Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty (TYPHOON) Trial Presented at.
16-year follow-up of the DANish Acute Myocardial Infarction 2 (DANAMI-2) trial PG Thranea, SD Kristensena, KKW Olesena, LS Mortensenb, HE Bøtkera, L.
Presentation transcript:

Primary PCI Monitoring Performance Produced by Paul Arnold Clinical Quality Department Date: 09th November 2012 1

Overview of the Performance Data Service Total Overview Primary PCI Pathway Activations (1st October 11 – 31st October 12) PPCI Pathway Activations (1404) n4 Incorrect use of Pathway x4 NON- PPCI (458) PCI attempted (946) n44 TBC n2 N452 Correct use NO PPCI x44 n408 n139 All genuine activations Incorrect activations x139 n269 n4 Last 12 months analyse To unwell to perform x2 procedure Patient refuse consent x1 Other x1 All suspected MI cases Managed as PPCI n266 n172 Angiography performed Not an MI – NO PCI x172 2

Overview of the Performance Data Service Total Overview Primary PCI Pathway Activations (1st October 11 – 31st October 12) PPCI Pathway Activations (1404) n94 n94 PCI not indicated – x40 Occlusion small vessel Surgical disease x36 To unwell to perform PCI x9 PCI indicated but x7 Not possible/ attempted Early Deaths x2 Potential culprit lesion confirmed N946 PCI procedure attempted TBC (5) Done PCI failed (22) PCI partial success (27) TIMI 3 (892, 94.7%) 3

Contents Data Review 01.10.11 – 31.10.12 1404 Primary PCI pathway activations identified. Of which, 67.3% (946/ 1404) had a PPCI. - 43 Inpatients excluded in CTB figures only - 903 were analysed in CTB data Overview of the Performance Data Service Total Overview Admission Source PPCI activations CTB analysis DTB analysis PPCI Success Rate Summary Statistics by Consultant Mortality rate Discussion Thanks Done

Key Summary Statistics Overall Admission Source done NB: Inter-hospital INP were excluded as part of MINAP CTB criteria 5

Key Summary Statistics Primary PCI: Pathway Activations Jan 2011 > Oct 2012 Done

Key Summary Statistics Primary PCI: Call-to-Balloon Call or Self-Present Balloon 7

Key Summary Statistics Primary PCI: CTB Time Performance (Oct 2011 – Oct 2012) Done Median 103mins (Last <12months) n903

Key Summary Statistics Primary PCI: Overall CTB 120 Yearly Performance Done Median 103mins (Last <12mths)

Key Summary Statistics Primary PCI: CTB Time Performance (Oct 2011 – Oct 2012) Median 103mins (Last <12months) n903

Key Summary Statistics Primary PCI: Overall CTB 150 Yearly Performance Done Median 103mins (Last <12months)

Key Summary Statistics Overall Success CTB (Target 120mins) Done Median 103mins (Last <12mths) National target 150minutes CTB (80.6% compliant: last< 12mths) 12

Key Summary Statistics Overall Direct Success CTB (Target 120mins) Done Median 89mins (Last <12mths) National target 150minutes CTB (98.6% compliant: last< 12mths) 13

Key Summary Statistics Overall Inter-Hospital Transfer Success CTB (Target 120mins) Done Median 140mins (Last <12months) National target 150minutes CTB (58% compliant : last< 12mths) 14

Key Summary Statistics Median Interval times for > Inter-Hospital Transfers (Oct 2011 – Oct 2012) Done

Key Summary Statistics LHCH -> Balloon LHCH Door Balloon

Key Summary Statistics Overall patients treated within DTB Target 90mins done Median 34mins (Last <12months) N946 17

Key Summary Statistics Overall Success of PPCI done

Key Summary Statistics Overall Summary Statistics by Consultant   No. of cases Complete Success % Mortality % Andron 103 97 3 2.9 Appleby 99 3.0 Khand 102 89 Mills 290 93 12 4.1 Morris 286 94 11 3.8 Morrison 299 3.6 Munir 54 96 1 1.8 Palmer 353 95 13 Perry 297 4.0 Stables 302 92 10 3.3 Ramsdale 197 5 2.5 Velavan 185 4 2.1 Fisher 6 83 -

Key Summary Statistics Length of Stay on CCU Target 12 hours

Key Summary Statistics Overall Average Length of Stay on CCU done 21

Key Summary Statistics Total Length of Stay in Hospital 72 hour target

Key Summary Statistics Total Length of Stay (Aug 2011 – Aug 2012) Done N946 23

Key Summary Statistics Overall In-Hospital Mortality in STEMI Inpatients admitted for PPCI done 24

Key Summary Statistics Overall In-Hospital Mortality in Patients that Underwent a PPCI done 25

Key Summary Statistics Primary PCI: In-Hospital Mortality (Oct 2011 – Oct 2012) done N946 26

Any Questions 27